Improved Synthesis of Antihepatitis C Virus Drug Daclatasvir Dihydrochloride

XING Linfeng; MENG Dongshuo; JIN Jiayu; LIU Yu

doi:10.16522/j.cnki.cjph.2025.07.003

Chinese Journal of Pharmaceuticals, Volume. 56, Issue 7, 857(2025)

Improved Synthesis of Antihepatitis C Virus Drug Daclatasvir Dihydrochloride

XING Linfeng^1,2,3, MENG Dongshuo^2,3, JIN Jiayu¹, and LIU Yu^2,3、*

Author Affiliations

¹Shanghai Desano Medicine Co., Ltd., Shanghai 201203

²Incubation Center for Science and Technology Achievements, China State Institute of Pharmaceutical Industry Co., Ltd., Shanghai 201203

³National Key Lab. of Lead Druggability Research, Shanghai Institute of Pharmaceutical Industry Co., Ltd., China State Institute of Pharmaceutical Industry Co., Ltd., Shanghai 201203

show less

Abstract Get PDF(in Chinese)

Figures & Tables(0)

Tools

Get Citation

Copy Citation Text

XING Linfeng, MENG Dongshuo, JIN Jiayu, LIU Yu. Improved Synthesis of Antihepatitis C Virus Drug Daclatasvir Dihydrochloride[J]. Chinese Journal of Pharmaceuticals, 2025, 56(7): 857

Download Citation

EndNote(RIS)BibTex Plain Text

Set citation alerts for article

Save article for my favorites

Paper Information

Category:

Received: Feb. 24, 2025

Accepted: Aug. 26, 2025

Published Online: Aug. 26, 2025

The Author Email: LIU Yu (liuyu_tianjin@126.com)

DOI:10.16522/j.cnki.cjph.2025.07.003

Topics